INS and type 2 diabetes mellitus: Alhwiesh et al. [16] conducted an observational study that included fifty patients with T2DM and ESKD on APD with Baxter’s Home Choice Claria, who were receiving insulin treatment and were prescribed dapagliflozin at 10 mg per day.